Simon Saxby Joins Board at Selcia
News Jun 28, 2010
Simon Saxby is currently Vice-President Biologics of RecipharmCobra Biologics, a Swedish contract development and manufacturing company and has worldwide responsibility for the manufacturing of biologics. Simon has over 25 years experience in the biotechnology industry, including several CEO positions, most recently at Cobra Biomanufacturing plc and Alpha Biologics. He brings a blend of technical, business, sales and marketing skills and senior management, fund-raising and M&A experience.
Commenting on the appointment, Managing Director of Selcia, Dr Hans Fliri said: “I am delighted to welcome Simon to the management team. Simon brings with him his considerable international experience, technical knowledge and commercial expertise. We look forward to Simon helping us accelerate our UK and international market development plans”.